Latest filing published 02 Mar 2018 for Opus Genetics, Inc..
Insider track record
Peter David Suzdak: trading record in brief
Peter David Suzdak appears in our data through filings on Opus Genetics, Inc. shares, published by SEC (Form 4). Between 18 March 2016 and 28 February 2018, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 2 March 2018 came the latest disclosure, an option exercise in Opus Genetics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter David Suzdak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,250 shares0Common StockSEC:0001140361-18-011646:0
- 10,000 shares@ US$1.9949.7% of flowCommon StockSEC:0001140361-17-032420:0
- 60,000 shares@ US$0.323150.3% of flowCommon StockSEC:0001140361-16-058648:0
3 of 3 declarations
